BSE filing, NSE: KOKUYOCMLN. Summary written from the filing by ALFA Finder's alert engine.
Kokuyo Camlin Ltd: key numbers
- Share price
- ₹71.10
- Market cap
- ₹713.2 Cr
- Revenue (annual)
- ₹806.0 Cr
- Net profit (annual)
- ₹24.79 Cr
- P/E (TTM)
- 32.4×Sector 36.4×
- Promoter holding
- 74.99%+0.00% QoQ
- FII holding
- 0.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kokuyo Camlin Ltd
All →Kokuyo Camlin Board Meeting Date
Kokuyo Camlin will hold a board meeting on 4 November 2026 to consider unaudited Q2 and half-year September 2026 results. The trading window stays closed until 48 hours after the results are declared.
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a notice from the Registrar of Companies under Section 206(1) of the Companies Act regarding historical records, employee fraud, and inventory discrepancies.
- From
- Registrar of Companies (ROC), Rajasthan
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a GST demand order totaling Rs.7.80 Lakhs, including tax, interest, and penalty. The company intends to file an appeal.
- Value
- ₹0.08 Cr
- From
- Office of the Assistant Commissioner
Kokuyo Camlin Legal & Regulatory
Kokuyo Camlin received a GST demand order from the Assistant Commissioner, Chennai, totaling Rs. 1.12 Crore including interest and penalty. The company plans to appeal.
- Value
- ₹1.12 Cr
Kokuyo Camlin Annual General Meeting
Kokuyo Camlin held its 79th Annual General Meeting on August 6, 2026. The company transacted ordinary and special business items during the meeting.
Kokuyo Camlin Management Change
Kokuyo Camlin Limited appointed Ms. Urvi Upadhyay as Company Secretary and Ms. Sarika More as Interim Company Secretary. These key management changes were approved by the board.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.